Multiple Response Optimization of a HPLC Method for Analyzing Resorcinol and 4-<i>n</i>-Butyl Resorcinol in Lipid Nanoparticles

Resorcinol and 4-n-butyl resorcinol have been used to improve skin health. However, these two compounds were unstable due to the oxidation process. Lipid nanoparticle formulation strategies were reported as the solution to overcome the stability problem for both resorcinol and 4-n-butyl resorcinol....

Full description

Saved in:
Bibliographic Details
Main Authors: Rini Dwiastuti, Dina Christin Ayuning Putri, Maywan Hariono, Florentinus Dika Octa Riswanto
Format: article
Language:EN
Published: Department of Chemistry, Universitas Gadjah Mada 2021
Subjects:
Online Access:https://doaj.org/article/2e7e63b4d98f487aa0f91853a006b8b4
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Resorcinol and 4-n-butyl resorcinol have been used to improve skin health. However, these two compounds were unstable due to the oxidation process. Lipid nanoparticle formulation strategies were reported as the solution to overcome the stability problem for both resorcinol and 4-n-butyl resorcinol. Nevertheless, it is important to determine the content of resorcinol and 4-n-butyl resorcinol in lipid nanoparticle formulation. Aiming to develop the analytical method for resorcinol and 4-n-butyl resorcinol determination, a response surface methodology (RSM) was applied in the HPLC optimization stage. An optimized HPLC condition was obtained by generating a Box-Behnken design followed by multiple response analysis. It was obtained that optimized HPLC conditions due to the predictive multiple response optimization were methanol percentage of 50.0%, acetonitrile percentage of 18.1%, and flow rate of 0.6 mL min–1. This optimized condition was successfully applied and met the requirements of the system suitability test. Quantitative estimation was performed and resulted that the resorcinol and 4-n-butyl resorcinol content in lipid nanoparticles were 70.37 ± 0.47 and 95.07 ± 0.80 µg mL–1, respectively.